Acadia Pharmaceuticals buy UBS Group AG
Start price
15:00
/
50%
€24.89
Target price
17.08.27
-
Performance (%)
0.64%
Price
22:25
€25.05
Summary
This prediction is currently active. Since the start of the prediction for Acadia Pharmaceuticals the price has only changed by 0.64%. This prediction currently runs until 17.08.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Acadia Pharmaceuticals | 0.64% |
| iShares Core DAX® | 0.437% |
| iShares Nasdaq 100 | 1.057% |
| iShares Nikkei 225® | 1.769% |
| iShares S&P 500 | 0.368% |
Comments by UBS_Group_AG for this prediction
In the thread Acadia Pharmaceuticals diskutieren
ACADIA Pharmaceuticals (ACAD) had its "buy" rating reaffirmed by UBS Group AG.
Ratings data for ACAD provided by MarketBeat
Stopped prediction by UBS_Group_AG for Acadia Pharmaceuticals
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€23.07
06.01.26
06.01.26
€34.12
06.01.27
06.01.27
8.58%
22:25
22:25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€20.96
09.09.25
09.09.25
€33.13
09.09.26
09.09.26
19.51%
22:25
22:25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.15
08.08.25
08.08.25
€30.87
08.08.26
08.08.26
18.82%
09.08.26
09.08.26
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€14.56
08.08.24
08.08.24
€21.10
08.08.25
08.08.25
43.94%
09.08.25
09.08.25
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.80
17.10.23
17.10.23
€31.28
17.10.24
17.10.24
-36.33%
18.10.24
18.10.24

